Peritoneal Effluent MMP-2 and PAI-1 in Encapsulating Peritoneal Sclerosis-Reference-Cited by-同舟云学术

Peritoneal Effluent MMP-2 and PAI-1 in Encapsulating Peritoneal Sclerosis

Published:2015-05 Issue:5 Volume:65 Page:748-753
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Lopes Barreto Deirisa,Struijk Dirk G.,Krediet Raymond T.

Publisher

Elsevier BV

Subject

Nephrology

Reference26 articles.

1. Sclerosing peritonitis: the experience in Australia;Rigby;Nephrol Dial Transplant,1998

2. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis;Balasubramaniam;Nephrol Dial Transplant,2009

3. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes;Johnson;Kidney Int,2010

4. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients;Dobbie;Adv Perit Dial,1990

5. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells;Yanez-Mo;N Engl J Med,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Derazantinib Inhibits the Bioactivity of Keloid Fibroblasts via FGFR Signaling;Biomedicines;2023-12-05

2. Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFκΒ pathway inhibition;Kidney International;2023-11

3. Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy;Internal Medicine;2023-11-01

4. Current Insights into Cellular Determinants of Peritoneal Fibrosis in Peritoneal Dialysis: A Narrative Review;Journal of Clinical Medicine;2023-06-30

5. Recent Understanding and Future Directions in the Application of MMP-2 in Encapsulating Peritoneal Sclerosis Clinical Practice;Blood Purification;2023